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Abstract
Background: Intraoperative cone‐beam computed tomography (CBCT) offers the
advantage of navigation on the current anatomical situation and the possibility to
take a control scan. We assessed the feasibility of using intraoperative CBCT for nav-
igated intralesional curettage.
Methods: Nine benign bone tumour patients were studied. Feasibility was assessed
by describing the workflow and indications for navigation, scoring CBCT image qual-
ity and registration accuracy, and measuring scan and navigation set‐up times. Short‐
term follow‐up was described.
Results: CBCT navigation was successful in all patients. Median tumour visibility,
tumour delineation, and vital structure visibility scores were good. Median registra-
tion accuracy score was very good. Median scan and verification times were 5 and
3 minutes, respectively. One patient had a tumour recurrence after 6 months.
Conclusions: Intraoperative CBCT navigation is feasible and safe. Indications for
use of navigation in clinical practice are closeness to vital structures, complexly
shaped tumours or bone, minimally invasive surgery, and repeated surgery.
KEYWORDS
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1 | INTRODUCTION
Primary bone tumours are rare, ie, the proportion of malignant bone
tumours is 0.2% of all cancer in the Western population.1 The exact
incidence of benign and intermediate‐grade bone tumours is unclear,
as often cases go undetected because of lack of symptoms.2 The most
common treatment for symptomatic nonmalignant tumours comprises
intralesional curettage with or without local adjuvant treatment.3
The current standard intraoperative imaging technique used to
support the orthopaedic surgeon is two‐dimensional (2D) fluoroscopy.
The major limitation of this method is that it lacks the detail for
depicting challenging cases. Tumours in the proximal or distal parts
of long bones, as well as in irregularly shaped bones, are not easily dis-
tinguishable on fluoroscopy. Difficult tumour localization and poor
visualization may result in (microscopic) tumour residue leading to
local recurrence and repeated surgery. It may also lead to damaged
healthy tissue and subsequent function loss.
Surgical navigation, an application of computer‐assisted surgery, pro-
vides real‐time feedback of the surgical instrument position using high‐
resolution three‐dimensional (3D) images. Navigation has been used in
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malignant bone tumour resections in the pelvis since 2004,4 and applica-
tions have expanded to other bones and limb salvage surgery.5-9 Naviga-
tion is not yet commonly used for intralesional curettage.10
To enable navigation during surgery, a 3D image dataset is linked
to the patient through a process called registration. Registration is
almost always manual and based on computed tomography (CT)
images. Magnetic resonance imaging (MRI) becomes available for nav-
igation by image fusion with the CT images.11
An intraoperative cone‐beam CT (CBCT) scanner enables CT‐like
quality 3D scans in the operating room (OR). Intraoperative CBCT
offers the advantage of navigation on the current anatomical situation
and the possibility to take a control scan to verify complete tumour
removal. The CBCT is automatically registered to the patient, without
manual user input. The combination of CBCT and navigation is com-
monly used for pedicle screw placement12 but is not yet applied in
bone tumour surgery.
We recently started using navigation for benign bone tumours in
difficult anatomical locations. As our centre has a hybrid OR, our aim
is to explore the feasibility of using intraoperative CBCT to set up nav-
igation in patients with benign bone tumours. In this pilot study, we
describe the workflow, indications for usage of navigation, image qual-
ity, registration accuracy, procedure and set‐up times, and short‐term
follow‐up.
2 | MATERIALS AND METHODS
2.1 | Study population and design
From January 2017 to November 2017, nine consecutive patients
(median age, 36 years; age range 11‐56 years) with different types
of benign bone tumours (Table 1) were enrolled in this study. This
study comprises a prospective case series. Inclusion criteria were
benign bone tumour and the need to undergo navigated curettage.
There were no exclusion criteria. The study was exempted from
approval by the ethics committee because the CBCT scanner and nav-
igation system are already used in clinical practice. Informed consent
was obtained from all patients.
2.2 | Preoperative planning
As bone tumours can occur in every bone of the body, a preoperative
position planning of patient, optical camera (Curve, Brainlab, Munich,
Germany), and reference base was made for every patient (Figure 1
A). This planning was then executed during surgery (Figure 1B). The
(A)
(B)
FIGURE 1 A‐B, The preoperative position planning for patient 9 (A),
depicting how to position the patient, where to place the navigation
system and camera, and where to place the reference base. The red
circle indicates the lesion in the C7 vertebra; (B) shows the actual
situation during surgery
TABLE 1 Patient and procedure characteristics
Patient
No. /sex/age Tumour Type Tumour Size, mm Tumour Location Surgery Performed
1/M/14 Atypical cartilaginous tumour 16 × 20 × 18 Proximal humerus (right) Curettage + cryo + bone graft
2/F/11 Subchondral cysts 1: 12
2: 8
Proximal tibia (left) Curettage + bone graft
3/M/21 Chronic osteomyelitis 43 × 12 × 9 Distal femur (right) Curettage + flush
4/M/17 Osteochondroma 14 Distal radius (left) + ulna (left) Resection
5/M/38 Reactive cyst 71 × 61 × 61 Acetabulum (right) Curettage + cryo + bone graft
6/M/56 Atypical cartilaginous tumour 58 × 34 × 32 Proximal humerus (right) Curettage + cryo + cement
7/F/51 Giant cell tumour 41 × 41 × 32 Proximal tibia (left) Curettage + cryo + bone graft
8/F/48 Osteoid osteoma 13 Spinous process C7 Curettage
9/M/36 Intraosseous ganglion 34 × 43 × 35 Proximal tibia (right) Curettage + bone graft
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CBCT scanner (Artis Zeego, Siemens Healthineers, Erlangen, Germany)
is a floor‐mounted multi‐axis robotic C‐arm system. A CBCT is made
by isocentric rotation of the C‐arm. The acquired projection images
are reconstructed to a 3D volume. The patient was positioned accord-
ing to preoperative planning on an operating table with a radiolucent
carbon fibre table top (MAQUET MAGNUS, MAQUET, Rastatt, Ger-
many). Its static floor mount limits the C‐arm range of motion to the
proximal half of the operating table. Patients were positioned head
first towards the scanner for tumours located in the spine and upper
extremity, and feet first for tumours located in the pelvis and lower
extremity. The tumour was positioned in the isocenter of the 3D scan.
For example, a patient with a tumour in the humerus was positioned
laterally on the laterally extended table. A thin gel mattress was used
to prevent collision between patient and C‐arm during the 3D run. A
collision check was performed before draping. If a 3D run was not
possible, the patient was repositioned.
The C‐arm also limited the initial optical camera position, as its reflec-
tive tracking stickers should be visible to the camerawhen starting the 3D
run (Figure 2). During surgery, the camera could bemoved freely. The ref-
erence base was placed on the affected bone between the operating field
and the optical camera. If this was not possible, camera and reference
positions were planned so that the line of sight between the camera
and reference base was not obstructed by the surgeon during surgery.
2.3 | Cone‐beam CT navigation
All patients underwent treatment under general or epidural anaesthe-
sia. All procedures were performed by one orthopaedic surgeon (I.v.d.
G., 9 years of experience in orthopaedic oncology). Two pins 4 mm in
diameter were drilled percutaneously in the affected bone, on which
the reference base was clamped. For patient 8 (see also Table 1), the
reference base was clamped to the spinal process of the T1 vertebra.
The CBCT imaging protocol was based on patient size and tumour
location. The low‐dose protocol (5 s DynaCT Body Care) takes 133 pro-
jection images, whereas the high‐dose protocol (6 s DynaCT Body) takes
397 projection images. More projections resulted in higher image quality,
required for body parts with more mass, at the cost of a higher radiation
dose. The resulting images were automatically registered to the patient,
because the C‐arm was previously calibrated and is tracked using reflec-
tive stickers (Figure 2). The registration accuracy was validated visually by
the surgeon using a navigated pointer (Figure 3A). Either the curette or
high‐speed burr (Midas Rex,Medtronic,Minneapolis, USA)was calibrated
and navigated throughout the treatment (Figure 3B). Navigation was
used both as a confirmation of position and to assess direction. In case
of uncertainty about entire tumour removal, a control CBCT scan was
acquired with the possibility of directly continuing navigation based on
the current anatomical situation.
2.4 | Analyses
As this is a feasibility study, we mainly used descriptive statistics, ie,
mean/median imaging and navigation parameters, procedural dura-
tions, and image quality.
Technical success was defined as properly setting up CBCT naviga-
tion and having this available for the surgeon throughout the procedure.
In order to define indications for the use of CBCT navigation that
can be applied to all variations in benign bone tumours, the surgeon
was asked to list the reasons for the use of navigation per patient
and if navigation was of added value.
Imaging protocols and dose area products (DAP) were collected from
the database. DAP is defined as the absorbed dose over the irradiated
area and includes all scans and fluoroscopy images made during surgery.
CBCT image quality for each of the patients was scored by a radi-
ologist (J.J.F., 9 years of experience in interventional radiology) and
the orthopaedic surgeon on a five‐point scale ranging from 1 to 5, cor-
responding to very poor, poor, acceptable, good, and very good image
quality. This scale was used to score tumour visibility, tumour delinea-
tion, and the visibility of vital structures. The Cohen's kappa coeffi-
cient (κ) was calculated using IBM SPSS Statistics version 25.0 (IBM,
Armonk, NY) to measure interrater agreement.
The registration accuracy was scored by the orthopaedic surgeon
using the same five‐point scale as was used to score the image quality.
The scoreswere retrospectively obtained based on validation images that
were recorded during the registration validation step (see also Figure 3A).
Surgical time was defined as the time between the first incision
and last suture. These times were extracted from the anaesthesiology
logs. Setting up navigation was split into acquiring the CBCT and val-
idating the registration. These times were extracted from the naviga-
tion system logs. The scan time started when the C‐arm was moved
to the operating table and ended after acquiring the 3D volume. The
validation time started directly after acquiring the CBCT and ended
after the registration was accepted. Validation thus also included mov-
ing all instrument tables and monitors back into place, as well as prop-
erly visualizing the CBCT. The duration of a possible control scan was
not included in the scan time.
FIGURE 2 This is the starting position of the C‐arm before acquiring
a 3D scan. The black circles indicate the reflective calibration stickers
that allow the navigation system to “see” the C‐arm. The camera
needs to have a clear line of sight to these stickers when starting the
3D run, otherwise the system cannot perform an automatic image
registration
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Clinical follow‐up data was extracted from the patient manage-
ment system.
3 | RESULTS
3.1 | Indications
CBCT navigation was a technical success in all nine cases. The surgeon
reported added value of CBCT navigation in all cases with the excep-
tion of patient 4. This patient had an ulnar deformation due to multiple
osteochondroma, and an osteochondroma had to be removed. The
deformation made it difficult to see the osteochondroma in all planes,
and thus navigation had no added value in resection of the lesion. Rea-
sons to use navigation are listed in Table 2.
Patients 1 and 2 underwent an intraoperative control scan to
check if complete tissue removal was achieved. For patient 1, the scan
showed no complications. Patient 2 had subchondral cysts (Figure 4A).
After initial curettage, the control scan revealed a small cyst was still
partially intact, so curettage was extended to this part of the lesion
(Figure 4B).
3.2 | Image quality and registration accuracy
Patients 5 and 6 were imaged using the high‐dose protocol, because
the pelvis and thorax have a relatively high mass. The proximal
humerus of patient 1 could be imaged with the low‐dose protocol
because of his age and smaller body size. The DAP data for patient
2 were missing from our registration system.
The image quality scores are reported in Table 3. Both the radiolo-
gist and orthopaedic surgeon gave the tumour visibility and tumour
delineation a median score of “good.” The orthopaedic surgeon gave
the vital structure visibility and registration accuracy a median score
of “very good.” The κ was 0.37, 0.40, and 0.12 for tumour visibility,
tumour delineation, and vital structure visibility, respectively, without
FIGURE 3 A‐B, The validation and navigation view for patient 6, who had an atypical cartilaginous tumour in the proximal right humerus. A, The
surgeon has to validate the automatic registration using the navigated pointer by following the bony surface and visually verifying the navigation
view. B, After removing the tumour with the navigated curette, the surgeon checks the cavity for potential tumour residue
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statistical significance. Only for patient 4 were some characteristics
rated “poor.” Because of the severity of the deformations, the arm
had to be placed on the abdomen instead of above the head. The
low‐dose image protocol proved not to be suitable for this amount
of tissue. The large difference in tumour visibility scores for patient
4 might be because navigation was of no benefit to the orthopaedic
surgeon. Furthermore, the helpfulness of navigation in preserving
the spinal cord for patient 8 can explain the difference in vital struc-
ture visibility score between the orthopaedic surgeon and radiologist.
The registration accuracy could not be scored for patients 2 and 3.
No validation images were recorded during registration accuracy
assessment for these patients. For the other seven patients, the regis-
tration accuracy had a median score of 5 (range 2‐5). Patient 4 was
scored a 2, indicating a poor registration (Table 2).
3.3 | Procedure and set‐up times
All procedure and set‐up times are listed inTable 4. The median proce-
dure time was 85 minutes (range 54‐104 minutes). The median scan
time was 5 minutes (range 2.5‐15.5 minutes), and the median verifica-
tion time was 3 minutes (range 2‐5.5 minutes).
3.4 | Follow‐up
The follow‐up data after 2 months, consisting of an X‐ray and a visit to
the surgeon, are summarized for all patients in Table 5. Only patient 7
showed potential tumour residue on X‐ray imaging. An MRI after
6 months revealed tumour recurrence. Patient 8 had a small avulsion
fracture. Patient 4 did not return for follow‐up, as this is not required
for osteochondroma.
4 | DISCUSSION
It was feasible to use CBCT to set up navigation for benign bone
tumour surgery. Navigation allowed control on tumour removal and
tissue preservation. Indications for the use of CBCT navigation were
(1) closeness to vital structures; (2) complexly shaped tumours or
bone; (3) minimally invasive surgery; and (4) repeated surgery. The
main indication for 60 navigated curettages by Gerbers et al10 was
large lesions located in difficult anatomical locations. Our study
extends these indications in order to help other centres that want to
selectively employ surgical navigation for benign bone tumours.
The majority of our patients either had a good or very good CBCT
image quality. The κ was low, but both observers agreed image quality
was at least acceptable in all but one patient. High‐dose protocols can
be used for body parts with a high mass, such as the pelvis or shoul-
ders. The use of a low‐dose protocol for a high‐mass body part may
result in image quality that is unfit for surgical navigation. However,
a low dose should be considered whenever possible as this can reduce
patient radiation exposure by a factor three while maintaining image
quality.12 Literature suggests that drawbacks of intraoperative 3D
TABLE 2 Imaging and navigation characteristics
Patient No. Scan Protocol
Total Dose Area
Product (DAP), Gy.cm2
Registration
Accuracy Reason for Navigation Added Value
1 Low dose 16.17a 5 Close to open growth plate
Close to joint
Bone shape poorly visible on fluoroscopy
Repeated surgery (tumour residue)
Yes
2 Low dose N/Ab N/Ac Close to open growth plate
Close to joint
Bone shape poorly visible on fluoroscopy
Yes
3 Low dose 8.22 N/Ac Bone shape poorly visible on fluoroscopy
Repeated surgery (tumour residue)
Yes
4 Low dose 9.26 2 Tumour shape poorly visible on fluoroscopy No
5 High dose 42.15 4 Bone shape poorly visible on fluoroscopy
Close to joint
Yes
6 High dose 43.49 5 Bone shape poorly visible on fluoroscopy
Close to joint
Yes
7 Low dose 4.16 5 Bone shape poorly visible on fluoroscopy
Close to joint
Yes
8 Low dose 3.44 5 Minimally invasive surgery
Close to spinal cord
Yes
9 Low dose 0.49 5 Bone shape poorly visible on fluoroscopy
Close to joint
Yes
aThis total DAP includes both an initial CBCT and a control scan of the same dose protocol.
bNot available (N/A). The DAP data for this patient was missing from our registration system.
cNo validation images were recorded during registration accuracy assessment for these patients.
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images are poor quality and a partial volumetric view.13 The CBCT
image volume with an 18.5‐cm height and 24‐cm diameter is limited,
but every tumour in this study was small enough to be visualized
completely together with surrounding vital structures. Gerbers
et al10 argued that navigation can be used for curettage when a CT
dataset is available. Most of our bone tumour patients, however, did
not have a CT scan available, so one had to be acquired either preop-
eratively or intraoperatively in order to use navigation. Our results
suggested that intraoperative CBCT provides sufficient quality to be
an alternative to preoperative CT.
The intraoperative CBCT was automatically registered to the
patient with a median accuracy score of very good. In literature, three
manual registration methods are commonly used: (1) pairing of ana-
tomical landmarks or fiducial markers14; (2) matching of a point cloud
with the bony surface5-10; and (3) matching two intraoperative fluoro-
scopic images with the 3D volume.15,16 The most frequently used reg-
istration method is surface matching. Its registration accuracy is
commonly reported as the root mean square (RMS) error between
the points and the matched surface13 and should be less than
1 mm.17 As automatic registration does not require user input, an
RMS error value cannot be calculated. The true registration error is,
however, not uniform over the navigated volume, but differs per loca-
tion.18 Visual verification using a pointer forces the surgeon to assess
the registration accuracy across the entire region of interest, which
may be more representative than a numerical value. Surface matching
requires a relatively large and irregularly shaped surface for accurate
registration. This might be possible for large resections, but small
tumours with barely exposed bone limit the registration accuracy.19
Surface matching also works poorly for long bones because of the sim-
ilar anatomy along its length.13 For these cases, automatic registration
with an intraoperative 3D scan, which does not require exposed bone
for matching, can be a more appealing alternative.
Various studies have reported an increased surgery time because
of the use of surgical navigation.9,11 Steps potentially costing addi-
tional time as compared to non‐navigated surgery were patient posi-
tioning, placing the reference base, acquiring a 3D scan, and
validating the automatic registration. Patient positioning was planned
beforehand and performed during the anaesthesiologic routine and
therefore did not cost extra time. Another study on CBCT navigation
did not report on patient positioning because of little variation in oper-
ating field for pedicle screw placement.12 The duration of reference
base placement was not measured. The median navigation set‐up time
was about 8 minutes. According to the literature, the duration of set-
ting up navigation using a preoperative CT scan in an experienced cen-
tre was on average 4:25 minutes (range 2:03‐5:40 minutes).20 This
measurement consisted of reference base attachment, manual image
registration, and validation. Navigation did not significantly increase
procedure time as compared with non‐navigated surgery according
to Gerbers et al.10 Another group reported on navigation time includ-
ing the osteotomy,17 which makes it difficult to compare with our set‐
up times; however, a learning curve was evident, so that navigation
times decreased. CBCT navigation set‐up time appears to be longer
than preoperative CT navigation set‐up time, but we found this
acceptable given the benefits of navigation. Our set‐up times may still
decrease because of the learning curve.
One of the nine patients had potential residual tumour at the
follow‐up X‐ray, which resulted in a tumour recurrence after
6 months. Another study by Gerbers et al,20 where two of 17 navi-
gation patients had potential tumour residue, showed similar results.
Here, the outcome of navigated curettage was compared with
fluoroscopy‐guided curettage of atypical cartilaginous tumours. No
significant difference in tumour residue rates between these two
groups was reported. It was suggested that navigated curettage
can be improved by implementing a feedback mechanism on treat-
ment progress.
FIGURE 4 A‐B, Axial slides of the CBCT of patient 2, showing
subchondral cysts in the proximal left tibia. (A) The CBCT before
curettage shows two cysts, while the control scan (B) reveals
incomplete removal of one of the cysts. Surgery was continued, and
the remaining cyst was removed
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Some potential limitations of this pilot study should also be
discussed. First, the number of patients is low and follow‐up is lim-
ited, which is inherent to a feasibility study. However, it is a quick
way of assessing feasibility and indicating points of improvement,
and it can be a starting point for further studies. Second, because of
the heterogeneity in benign bone tumour patients, it was not possible
to compare procedure times with a historical cohort to provide a
realistic estimation of the extra time needed to set‐up CBCT
navigation.
Hybrid operating theatres are becoming more widespread, while
clinicians and researchers are investigating new indications for intra-
operative 3D imaging. Challenging cases of benign bone tumours,
where fluoroscopy does not sufficiently visualize the area of interest,
may benefit from this technique. When preoperative CT navigation
is not possible, either because there is no CT scan available or too little
bone is exposed to perform an accurate registration, intraoperative
CBCT navigation could be an alternative. Intraoperative CBCT naviga-
tion was only used in selected cases with an expected health benefit,
so as to use the system efficiently because of its limited availability
and costs of usage.
Navigation was used during benign bone tumour curettage to
achieve better tumour control as compared with fluoroscopic guid-
ance. This is, however, not yet demonstrated. Not every patient in
this study had a control CBCT to show that the resection was accu-
rate. Instead, we will investigate how well a surgeon can resect
planned lesions in a cadaver study and verify this with control CBCT
scans. Moreover, current navigation software only shows where an
instrument is at any given time, but not where it has previously
been. Because treatment progress is not monitored, (microscopic)
tumour residue might remain. The residue rate after navigated bone
tumour surgery may be improved by software that updates which
parts of the delineated tumour were treated.20 To go from instru-
ment tracking to progress tracking requires dedicated software, as
well as preoperative treatment planning on MRI and intraoperative
image fusion. Once planning and execution of navigation is opti-
mized, we can set up an IDEAL stage 2b exploration study to
TABLE 3 Image quality scores on a five‐point scale (1 = very poor, 2 = poor, 3 = acceptable, 4 = good, 5 = very good)
Tumour Visibility Tumour Delineation Vital Structure Visibility
Patient No. Radiologist Orthopaedic Surgeon Radiologist Orthopaedic Surgeon Radiologist Orthopaedic Surgeon
1 4 4 4 4 4 5
2 5 5 5 5 5 5
3 5 4 4 4 4 5
4 4 2a 3 3 3 2
5 4 4 4 4 4 4
6 4 4 4 5 3 4
7 5 4 4 4 4 4
8 4 4 3 4 3 5
9 5 5 5 4 4 5
aImage quality scores below acceptable were underscored.
TABLE 4 Procedure times and set up duration
Patient
No.
Procedure Time,
minutes
Scan Time,
minutes
Validation Time,
minutes
1 96 15.5a 2.0
2 91 5.0 2.0
3 59 5.5 3.0
4 85 7.5b 4.5
5 94 5.5 2.5
6 68 3.0 5.5
7 104 3.0 4.0
8 54 2.5 2.5
9 59 5.0 5.0
aThe 15.5‐minute scan time for patient 1 occurred because of connection
problems between the CBCT scanner and the navigation system. After
the procedure, this problem was solved and never occurred again.
bThe 7.5‐minute scan time for patient 4 was caused by improper initial
patient positioning, which led to the C‐arm hitting the table during the col-
lision check.
TABLE 5 Follow‐up data after 2 months
Patient No. Complications on X‐ray
1 No
2 No
3 No
4 N/Aa
5 No
6 No
7 Recurrence
8 Avulsion fracture
9 No
aFor the patient with an osteochondroma (no. 4) follow‐up was not
required (N/A).
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investigate the clinical effects of navigated curettage by comparing it
with a control group.21
In conclusion, it is feasible and safe to use intraoperative CBCT to
set up navigation for benign bone tumour surgery. Indications for nav-
igation in daily clinical practice are closeness to vital structures, com-
plexly shaped tumours or bone, minimally invasive surgery, and
repeated surgery.
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